Cancer Driver Log (CanDL) Catalog of Potentially Actionable Cancer Mutations

被引:44
作者
Damodaran, Senthilkumar [1 ]
Miya, Jharna [2 ]
Kautto, Esko [2 ]
Zhu, Eliot [2 ]
Samorodnitsky, Eric [2 ]
Datta, Jharna [2 ]
Reeser, Julie W. [2 ]
Roychowdhury, Sameek [1 ,2 ,3 ]
机构
[1] Ohio State Univ, Div Med Oncol, Columbus, OH 43210 USA
[2] Ohio State Univ, Ctr Comprehens Canc, Dept Internal Med, Columbus, OH 43210 USA
[3] Ohio State Univ, Dept Pharmacol, Columbus, OH 43210 USA
关键词
VALIDATION; GENES; ONCOLOGY; DATABASE;
D O I
10.1016/j.jmoldx.2015.05.002
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Massively parallel sequencing technologies have enabled characterization of genomic alterations across multiple tumor types. Efforts have focused on identifying driver mutations because they represent potential targets for therapy. However, because of the presence of driver and passenger mutations, it is often challenging to assign the clinical relevance of specific mutations observed in patients. Currently, there are multiple databases and tools that provide in silico assessment for potential drivers; however, there is no comprehensive resource for mutations with functional characterization. Therefore, we created an expert-curated database of potentially actionable driver mutations for molecular pathologists to facilitate annotation of cancer genomic testing. We reviewed scientific literature to identify variants that have been functionally characterized in vitro or in vivo as driver mutations. We obtained the chromosome Location and all possible nucleotide positions for each amino acid change and uploaded them to the Cancer Driver Log (CanDL) database with associated Literature reference indicating functional driver evidence. In addition to a simple interface, the database allows users to download all or selected genes as a comma-separated values file for incorporation into their own analysis pipeline. Furthermore, the database includes a mechanism for third-party contributions to support updates for novel driver mutations. Overall, this freely available database will facilitate rapid annotation of cancer genomic testing in molecular pathology laboratories for mutations.
引用
收藏
页码:554 / 559
页数:6
相关论文
共 50 条
  • [41] Simultaneous Identification of Multiple Driver Pathways in Cancer
    Leiserson, Mark D. M.
    Blokh, Dima
    Sharan, Roded
    Raphael, Benjamin J.
    PLOS COMPUTATIONAL BIOLOGY, 2013, 9 (05)
  • [42] Germline mutations in Chinese ovarian cancer with or without breast cancer
    Kwong, Ava
    Ho, Cecilia Yuen Sze
    Shin, Vivian Yvonne
    Au, Chun Hang
    Luk, Wing Pan
    Fung, Ling Hiu
    Chan, Tsun-Leung
    Chan, Karen Kar Loen
    Ngan, Hextan Yuen Sheung
    Ma, Edmond Shiu Kwan
    MOLECULAR GENETICS & GENOMIC MEDICINE, 2022, 10 (07):
  • [43] Protocol for generation of humanized HCC mouse model and cancer-driver mutations using CRISPR-Cas9
    Zhu, Yicheng
    Tahara, Stanley M.
    Tsukamoto, Hidekazu
    Machida, Keigo
    STAR PROTOCOLS, 2023, 4 (04):
  • [44] Network-based prediction approach for cancer-specific driver missense mutations using a graph neural network
    Hatano, Narumi
    Kamada, Mayumi
    Kojima, Ryosuke
    Okuno, Yasushi
    BMC BIOINFORMATICS, 2023, 24 (01)
  • [45] Evaluation of whole genome sequencing utility in identifying driver alterations in cancer genome
    Nagashima, Takeshi
    Yamaguchi, Ken
    Urakami, Kenichi
    Shimoda, Yuji
    Ohnami, Sumiko
    Ohshima, Keiichi
    Tanabe, Tomoe
    Naruoka, Akane
    Kamada, Fukumi
    Serizawa, Masakuni
    Hatakeyama, Keiichi
    Ohnami, Shumpei
    Maruyama, Koji
    Mochizuki, Tohru
    Mizuguchi, Maki
    Shiomi, Akio
    Ohde, Yasuhisa
    Bando, Etsuro
    Sugiura, Teiichi
    Mukaigawa, Takashi
    Nishimura, Seiichiro
    Hirashima, Yasuyuki
    Mitsuya, Koichi
    Yoshikawa, Shusuke
    Kiyohara, Yoshio
    Tsubosa, Yasuhiro
    Katagiri, Hirohisa
    Niwakawa, Masashi
    Takahashi, Kaoru
    Kashiwagi, Hiroya
    Yasunaga, Yoshichika
    Ishida, Yuji
    Sugino, Takashi
    Kenmotsu, Hirotsugu
    Terashima, Masanori
    Takahashi, Mitsuru
    Uesaka, Katsuhiko
    Akiyama, Yasuto
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [46] dbCPM: a manually curated database for exploring the cancer passenger mutations
    Yue, Zhenyu
    Zhao, Le
    Xia, Junfeng
    BRIEFINGS IN BIOINFORMATICS, 2020, 21 (01) : 309 - 317
  • [47] miRNA Mediated Noise Making of 3′UTR Mutations in Cancer
    Wu, Wei
    Wu, Lingxiang
    Zhu, Mengyan
    Wang, Ziyu
    Wu, Min
    Li, Pengping
    Nie, Yumin
    Lin, Xue
    Hu, Jie
    Eskilsson, Eskil
    Wang, Qh
    Shao, Jiaofang
    Lyu, Sali
    GENES, 2018, 9 (11):
  • [48] Recurrent somatic mutations in regulatory regions of human cancer genomes
    Melton, Collin
    Reuter, Jason A.
    Spacek, Damek V.
    Snyder, Michael
    NATURE GENETICS, 2015, 47 (07) : 710 - +
  • [49] Gastric cancer actionable genomic alterations across diverse populations worldwide and pharmacogenomics strategies based on precision oncology
    Echeverria-Garces, Gabriela
    Ramos-Medina, Maria Jose
    Vargas, Rodrigo
    Cabrera-Andrade, Alejandro
    Altamirano-Colina, Adriana
    Freire, Maria Paula
    Montalvo-Guerrero, Juliana
    Rivera-Orellana, Sebastian
    Echeverria-Espinoza, Paulina
    Quinones, Luis A.
    Lopez-Cortes, Andres
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [50] New genes potentially involved in breast cancer metastasis
    Schwirzke, M
    Schiemann, S
    Gnirke, AU
    Weidle, UH
    ANTICANCER RESEARCH, 1999, 19 (3A) : 1801 - 1814